Patients start at a low starting dose and increase slowly through dose titration to reach a maintenance dose
Early Response Phase (Months 2-3) What to expect: Noticeable improvement in energy and motivation Better exercise recovery Possible initial changes in body composition Continued improvement in sleep Lab monitoring: First follow-up IGF-1 testing at 8-12 weeks
Most insurance plans still treat obesity as a lifestyle issue rather than a medical condition, which means coverage for drugs like Wegovy is often limited or excluded altogether
Acosta Groups study was conducted Feb
Global GLP-1 Receptor Agonist Market Research Report: Forecast (20262032) Global GLP-1 Receptor Agonist Market - By Product Type (Semaglutide, Ozempic, Wegovy, Rybelsus, Others, Liraglutide, Victoza, Saxenda, Others, Exenatide, Dulaglutide, Other (tirzep